Um die volle Funktionalität der Webseite nutzen zu können, müssen Sie JavaScript in ihrem Browser aktivieren.

DAX23.411,94-1,51 %

Gold3.434,14+1,44 %

Öl (Brent)74,19+6,56 %

Dow Jones42.146,96-1,86 %

US Tech 10021.623,55-1,29 %

EUR/USD1,15465-0,37 %

Top 15 der gesamten Suchanfragen der letzten 7 Tage

Login

Mangoceuticals Aktie

Aktie

ISIN: US56270V2051 SYM: MGRX Land Flagge US

USA

Zur Watchlist hinzufügen Zum Portfolio hinzufügen

Zum Portfolio hinzufügen

1,9800

USD

-1,49 %

-0,0300 USD

Letzter Kurs 21:35:53 Nasdaq

Mangoceuticals Aktie kaufen

Geldkurs

21:34:26

1,9500

USD

15.400 STK

Briefkurs

21:34:26

2,0000

USD

300 STK

BEI SMARTBROKER+ HANDELN

Handeln über unsere
Partner-Broker

Brokerize

Neueste Nachrichten

ArcStone Securities and Investments Corp. Publishes Industry Report on The Rapid Expansion of The Oral Stimulant Pouch Market 28.04.25 · newsfile · Nasdaq Inc. Aktie
CORRECTION FROM SOURCE: ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of IP Assets of Smokeless Technology Corp. Marking its Entry into the High Growth Oral 26.04.25 · newsfile · Bank of Montreal
ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of Smokeless Technology Corp. Marking its Entry into the High Growth Oral Stimulant Pouch Sector 25.04.25 · newsfile · Bank of Montreal
CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape 22.04.25 · Accesswire · Mangoceuticals
MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly 21.10.24 · globenewswire · Mangoceuticals
Mangoceuticals, Inc. Announces Participation at the Centurion One Capital 2nd Annual Bahamas Summit 2024 18.10.24 · newsfile · Mangoceuticals
MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN 11.10.24 · globenewswire · Mangoceuticals
MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions 03.10.24 · globenewswire · Mangoceuticals
MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment 01.10.24 · globenewswire · Mangoceuticals
MangoRx Reports 1,685% Increase in Shareholders’ Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024 15.08.24 · globenewswire · Mangoceuticals
MangoRx Receives Certificate of Grant in India for its Respiratory Illness and Preventive Care Technology Patent 13.08.24 · globenewswire · Mangoceuticals
MangoRx Completes Migration to DEA-Approved Telemedicine Platform, Accelerating Timeline of Oral Dissolvable GLP-1 Weight Loss Treatments Featuring Semaglutide and Tirzepatide 09.08.24 · globenewswire · Mangoceuticals

1
2

Meistgelesen

12 Monate

MangoRx Receives Certificate of Grant in India for its Respiratory Illness and Preventive Care ... 252 Leser
MangoRx Completes Migration to DEA-Approved Telemedicine Platform, Accelerating Timeline of Oral ... 192 Leser
MangoRx Reports 1,685% Increase in Shareholders’ Equity From December 31, 2023, to $13.8MM, and ... 184 Leser
MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN 180 Leser
CORRECTION FROM SOURCE: ArcStone Securities and Investments Corp. Serves as Exclusive Financial ... 144 Leser
ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals ... 128 Leser
CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape 124 Leser
MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly 124 Leser
MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets 116 Leser
ArcStone Securities and Investments Corp. Publishes Industry Report on The Rapid Expansion of The ... 116 Leser